Primary Analysis of KYV-101 for the Treatment of Stiff Person Syndrome by Madaline Spencer| Published on: May 18, 2026

Primary Analysis of KYV-101 for the Treatment of Stiff Person Syndrome by Madaline Spencer| Published on: May 18, 2026 Naji Gehchan, MD, MBA, Chief Medical and Development Officer at Kyverna Therapeutics, discusses primary analysis of KYV-101 for the treatment of stiff person syndrome (SPS). https://checkrare.com/primary-analysis-of-kyv-101-for-the-treatment-of-stiff-person-syndrome/